Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition ; volume:50 ; number:9 ; day:22 ; month:4 ; year:2023 ; pages:2621-2635 ; date:7.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 9 (22.4.2023), 2621-2635, 7.2023
- Urheber
-
Zboralski, Dirk
Osterkamp, Frank
Christensen, Esben
Bredenbeck, Anne
Schumann, Anne
Hoehne, Aileen
Schneider, Eberhard
Paschke, Matthias
Ungewiss, Jan
Haase, Christian
Robillard, Liliane
Simmons, Andrew D.
Harding, Thomas C.
Nguyen, Minh
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-023-06211-6
- URN
-
urn:nbn:de:101:1-2023093011120963280634
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zboralski, Dirk
- Osterkamp, Frank
- Christensen, Esben
- Bredenbeck, Anne
- Schumann, Anne
- Hoehne, Aileen
- Schneider, Eberhard
- Paschke, Matthias
- Ungewiss, Jan
- Haase, Christian
- Robillard, Liliane
- Simmons, Andrew D.
- Harding, Thomas C.
- Nguyen, Minh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control